5571 - 5580 of 9035 Results
Title
Year
- A randomized clinical trial of burst vs. spaced physical therapy for Parkinsons disease2022RESTRICTEDTitle: A randomized clinical trial of burst vs. spaced physical therapy for Parkinsons diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 57End Page: 62Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.021Citation Count: 12
- Subacute tremor and ataxia: Diligence in pursuit of a diagnosis2022RESTRICTEDTitle: Subacute tremor and ataxia: Diligence in pursuit of a diagnosisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 129End Page: 131Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.016Citation Count: 1
- Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension2022RESTRICTEDTitle: Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotensionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 99Issue #:Start Page: 62End Page: 64Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.002Citation Count: 3
- Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease2022RESTRICTEDTitle: Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 99Issue #:Start Page: 58End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.010Citation Count: 21
- L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome2022RESTRICTEDTitle: L-Dopa response, choreic dyskinesia, and dystonia in Perry syndromeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 100Issue #:Start Page: 19End Page: 23Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.023Citation Count: 8
- Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's disease2022RESTRICTEDTitle: Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 57End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.009Citation Count: 10
-
OPENTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 23
- Pallidal neuronal activity in multiple system atrophy type P and Parkinson's disease2022RESTRICTEDTitle: Pallidal neuronal activity in multiple system atrophy type P and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 15End Page: 17Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.007Citation Count: 1
- Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism2022RESTRICTEDTitle: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 39End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019Citation Count: 1
-
OPENTitle: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 139End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdfCitation Count: 15